Healthcare -
Biotechnology - NASDAQ - US
$ 2.11
9.33 %
$ 45.7 M
Market Cap
-0.73
P/E
ALRN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ALRN - Aileron Therapeutics, Inc.
16.2 M
LAST VALUE
56.55%
2 YEAR CAGR
-8.09%
5 YEAR CAGR
19.40%
10 YEAR CAGR